Extended dosing (12 cycles) vs conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high-grade gliomas: a randomized, single-blind, two-arm, parallel-group controlled trial.
Saved in:
| Title: | Extended dosing (12 cycles) vs conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high-grade gliomas: a randomized, single-blind, two-arm, parallel-group controlled trial. |
|---|---|
| Authors: | Anvari K; Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Seilanian Toussi M; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States., Saghafi M; Qazvin University of Medical Sciences, Qazvin, Qazvin, Iran., Javadinia SA; Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran., Saghafi H; Faculty of Medicine, Tehran Medical Branch of Islamic Azad University, Tehran, Iran., Welsh JS; Department of Radiation Oncology, Loyola University Chicago Stritch School of Medicine, Edward Hines Jr., VA Hospital, Maywood, IL, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2024 May 07; Vol. 14, pp. 1357789. Date of Electronic Publication: 2024 May 07 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38774410 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Extended dosing (12 cycles) vs conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high-grade gliomas: a randomized, single-blind, two-arm, parallel-group controlled trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Anvari+K%22">Anvari K</searchLink>; Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.<br /><searchLink fieldCode="AU" term="%22Seilanian+Toussi+M%22">Seilanian Toussi M</searchLink>; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.<br /><searchLink fieldCode="AU" term="%22Saghafi+M%22">Saghafi M</searchLink>; Qazvin University of Medical Sciences, Qazvin, Qazvin, Iran.<br /><searchLink fieldCode="AU" term="%22Javadinia+SA%22">Javadinia SA</searchLink>; Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.<br /><searchLink fieldCode="AU" term="%22Saghafi+H%22">Saghafi H</searchLink>; Faculty of Medicine, Tehran Medical Branch of Islamic Azad University, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Welsh+JS%22">Welsh JS</searchLink>; Department of Radiation Oncology, Loyola University Chicago Stritch School of Medicine, Edward Hines Jr., VA Hospital, Maywood, IL, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2024 May 07; Vol. 14, pp. 1357789. <i>Date of Electronic Publication: </i>2024 May 07 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38774410 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2024.1357789 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1357789 Titles: – TitleFull: Extended dosing (12 cycles) vs conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high-grade gliomas: a randomized, single-blind, two-arm, parallel-group controlled trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Anvari K – PersonEntity: Name: NameFull: Seilanian Toussi M – PersonEntity: Name: NameFull: Saghafi M – PersonEntity: Name: NameFull: Javadinia SA – PersonEntity: Name: NameFull: Saghafi H – PersonEntity: Name: NameFull: Welsh JS IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 05 Text: 2024 May 07 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
